If your institution subscribes to this resource, and you don't have an Access Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.
Download the Access App here: iOS and Android. Learn more here!
Herzuma16,170,171,*,#
Human epidermal growth factor receptor 2 (HER2)–directed monoclonal antibody
Biosimilar [not interchangeable] for trastuzumab (Rituxan);172 trastuzumab-dkst*; trastuzumab-dttb (2019 approval); pertuzumab
HER2-overexpressing breast cancer
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules > Trastuzumab
eChapter 2018 Part 2: The Goodman & Gilman Year in Review: 2018 New and Noteworthy FDA Approvals